It's a thin line between Ibuprofen and COVID-19
There is a lot of information on Covid-19 that is changing as we learn more about the virus. In the early days of the pandemic, there was concern that Ibuprofen could worsen Covid-19. It was based on a statement that reportedly came from France's health minister at the time. However, a new study is clarifying the issue.
the question over ibuprofen potential effect on Cove. It was not clear cut. The SARS cov to virus uses the ace two receptor to get into ourselves. And there was reason to believe that certain medications like ibuprofen might increase the number of ACE two receptors, which might lead to increased susceptibility to infection. At one point, agencies like the World Health Organization issued a recommendation to avoid the use of ibuprofen in Cove in 19 patients, but subsequently they've retracted it. Now, a new study published in the journal PLOS One is providing a direct answer. The researchers looked at data from over 9000 Danish citizens who tested positive for SARS cov to between February and April, off whom nearly 250 filled prescriptions for ibuprofen in the 30 days before their diagnosis. Compared to people who did not use ibuprofen, there was no difference in hospitalizations, the need for a nice you or deaths. The authors concluded that there was no reason to withhold ibuprofen solely because of a cove in 19 infection